SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 12, 2013
(Exact Name of Registrant as Specified in its Charter)
(State or Other Jurisdiction
3333 Susan Street
Costa Mesa, California 92626
(Address of principal executive offices, including zip code)
Registrants telephone number, including area code: (714) 662-5600
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):
|¨||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|¨||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|¨||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
|Item 8.01.||Other Events|
On February 12, 2013, Emulex Corporation and Endace Limited issued a joint press release announcing that Emulex had received acceptances for approximately 88.4% of the shares of Endace, has made its offer for Endace shares unconditional as to the level of acceptances and has extended the offer period to 1:00 pm (London time) on February 26, 2013. Emulexs offer had originally established acceptance by 90 percent or more of the voting rights in Endace as a condition to completion of the offer. A copy of the joint press release is attached hereto as Exhibit 99.1.
The information in Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Exchange Act and shall not be deemed incorporated by reference into filings under the Securities Act.
Item 9.01 Financial Statements and Exhibits.
|99.1||Joint press release of Emulex Corporation and Endace Limited, dated February 12, 2013|
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 13, 2013
|Michael J. Rockenbach|
|Executive Vice President and Chief Financial Officer|
|99.1||Joint press release of Emulex Corporation and Endace Limited, dated February12, 2013|